Heat Shock Protein 90: Inhibitors in Clinical TrialsBIAMONTE, Marco A; VAN DE WATER, Ryan; ARNDT, Joseph W et al.Journal of medicinal chemistry (Print). 2010, Vol 53, Num 1, pp 3-17, issn 0022-2623, 15 p.Article

Discovery of 4-aminomethylphenylacetic acids as γ-secretase modulators via a scaffold design approachZHILI XIN; HAIRUO PENG; CHOLLATE, Sowmya et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 24, pp 7277-7280, issn 0960-894X, 4 p.Article

Neuroprotective dimethyl fumarate synergizes with immunomodulatory interferon beta to provide enhanced axon protection in autoimmune neuroinflammationREICK, Christiane; ELLRICHMANN, Gisa; THÖNE, Jan et al.Experimental neurology (Print). 2014, Vol 257, pp 50-56, issn 0014-4886, 7 p.Article

Methylene amine substituted arylindenopyrimidines as potent adenosine A_2A/A₁ antagonistsSHOOK, Brian C; RASSNICK, Stefanie; WESTOVER, Lori et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 9, pp 2864-2867, issn 0960-894X, 4 p.Article

Β-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: Part 2. Optimization of α-amino substituentsYANG, Shyh-Ming; SCANNEVIN, Robert H; BINGBING WANG et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 3, pp 1140-1145, issn 0960-894X, 6 p.Article

Synapto-depressive effects of amyloid beta require PlCK1 : SYNAPTIC BASIS OF DISEASEALFONSO, Stephanie; KESSELS, Helmut W; DUNAH, Anthone W et al.European journal of neuroscience (Print). 2014, Vol 39, Num 7-8, pp 1225-1233, issn 0953-816X, 9 p.Article

Tolerability and Pharmacokinetics of Delayed-Release Dimethyl Fumarate Administered With and Without Aspirin in Healthy VolunteersSHEIKH, Sarah I; NESTOROV, Ivan; RUSSELL, Heidy et al.Clinical therapeutics. 2013, Vol 35, Num 10, pp 1582-1594, issn 0149-2918, 13 p.Article

Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs)ZHANG, Yue-Mei; XIAODONG FAN; YANG, Shyh-Ming et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 1, pp 405-408, issn 0960-894X, 4 p.Article

Extension of the Thrombolytic Time Window With Minocycline in Experimental StrokeMURATA, Yoshihiro; ROSELL, Anna; SCANNEVIN, Robert H et al.Stroke (1970). 2008, Vol 39, Num 12, pp 3372-3377, issn 0039-2499, 6 p.Article

Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathwayLINKER, Ralf A; LEE, De-Hyung; ELLRICHMANN, Gisa et al.Brain. 2011, Vol 134, pp 678-692, issn 0006-8950, 15 p., 3Article

Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategyWILSON, Lawrence J; BINGBING WANG; YANG, Shyh-Ming et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 21, pp 6485-6490, issn 0960-894X, 6 p.Article

Optimization of arylindenopyrimidines as potent adenosine A_2A/A₁ antagonistsSHOOK, Brian C; RASSNICK, Stefanie; ALFORD, Vernon et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 9, pp 2868-2871, issn 0960-894X, 4 p.Article

1-Hydroxy-2-pyridinone-based MMP inhibitors : Synthesis and biological evaluation for the treatment of ischemic strokeZHANG, Yue-Mei; XIAODONG FAN; JACKSON, Paul F et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 1, pp 409-413, issn 0960-894X, 5 p.Article

Β-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: Part 1. Design, synthesis, and lead identificationYANG, Shyh-Ming; SCANNEVIN, Robert H; BINGBING WANG et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 3, pp 1135-1139, issn 0960-894X, 5 p.Article

Induction of matrix metalloproteinase, cytokines and chemokines in rat cortical astrocytes exposed to plasminogen activatorsLEE, Sun-Ryung; GUO, Shu-Zhen; SCANNEVIN, Robert H et al.Neuroscience letters. 2007, Vol 417, Num 1, pp 1-5, issn 0304-3940, 5 p.Article